Prolonged corrected QT interval in patients with myotonic dystrophy type 1

Journal of Clinical Neurology (Korea)

Volumn 9, Issue 3, 2013, Pages 186-191

  Park, Kang Min ^a   Shin, Kyong Jin ^a   Kim, Sung Eun ^a   Park, Jinse ^a   Ha, Sam Yeol ^a   Kim, Byoung Joon ^b  

^a Inje University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Bazett's formula; Corrected OT interval; Myotonic dystrophy; Sudden cardiac death

Indexed keywords

EID: 84880056577     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2013.9.3.186     Document Type: Article

References (35)

1. Gharehbaghi-Schnell EB, Finsterer J, Korschineck I, Mamoli B, Binder BR. Genotype-phenotype correlation in myotonic dystrophy. Clin Genet 1998;53:20-26.
2. Pizzuti A, Friedman DL, Caskey CT. The myotonic dystrophy gene. Arch Neurol 1993;50:1173-1179.
3. Jaspert A, Fahsold R, Grehl H, Claus D. Myotonic dystrophy: correlation of clinical symptoms with the size of the CTG trinucleotide repeat. J Neurol 1995;242:99-104.
4. Mondelli M, Rossi A, Malandrini A, Della Porta P, Guzaai GC. Axo-nal motor and sensory neuropathy in myotonic dystrophy. Acta Neu-rol Scand 1993;88:141-148.
5. Meola G. Clinical and genetic heterogeneity in myotonic dystrophies. Muscle Nerve 2000;23:1789-1799.
6. Harley HG, Brook JD, Rundle SA, Crow S, Reardon W, Buckler AJ, et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992;355:545-546.
7. Aslanidis C, Jansen G, Amemiya C, Shutler G, Mahadevan M, Tsil-fdis C, et al. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 1992;355:548-551.
8. Harley HG, Rundle SA, MacMillan JC, Myring J, Brook JD, Crow S, et al. Size of the unstable CTG repeat sequence in relation to pheno-type and parental transmission in myotonic dystrophy. Am J Hum Genet 1993;52:1164-1174.
9. Ashizawa T, Dunne CJ, Dubel JR, Perryman MB, Epstein HF, Boer-winkle E, et al. Anticipation in myotonic dystrophy. I. Statistical verif-cation based on clinical and haplotype fndings. Neurology 1992;42: 1871-1877.
10. Melacini P, Villanova C, Menegazzo E, Novelli G, Danieli G, Rizzoli G, et al. Correlation between cardiac involvement and CTG trinucleo-tide repeat length in myotonic dystrophy. J Am Coll Cardiol 1995; 25:239-245.
11. Tokgozoglu LS, Ashizawa T, Pacifco A, Armstrong RM, Epstein HF, Zoghbi WA. Cardiac involvement in a large kindred with myotonic dystrophy. Quantitative assessment and relation to size of CTG repeat expansion. JAMA 1995;274:813-819.
12. Finsterer J, Gharehbaghi-Schnell E, Stöllberger C, Fheodoroff K, Seiser A. Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophy. Clin Genet 2001;59:350-355.
13. Sabovic M, Medica I, Logar N, Mandić E, Zidar J, Peterlin B. Relation of CTG expansion and clinical variables to electrocardiogram conduction abnormalities and sudden death in patients with myotonic dystrophy. Neuromuscul Disord 2003;13:822-826.
14. Pelargonio G, Dello Russo A, Sanna T, De Martino G, Bellocci F. Myotonic dystrophy and the heart. Heart 2002;88:665-670.
15. Mathieu J, Allard P, Potvin L, Prévost C, Bégin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999;52:1658-1662.
16. Glickstein JS, Schwartzman D, Friedman D, Rutkowski M, Axelrod FB. Abnormalities of the corrected QT interval in familial dysautono-mia: an indicator of autonomic dysfunction. J Pediatr 1993;122:925-928.
17. Lo SS, Mathias CJ, Sutton MS. QT interval and dispersion in primary autonomic failure. Heart 1996;75:498-501.
18. Deguchi K, Sasaki I, Tsukaguchi M, Kamoda M, Touge T, Takeuchi H, et al. Abnormalities of rate-corrected QT intervals in Parkinson's dis-ease-a comparison with multiple system atrophy and progressive su-pranuclear palsy. J Neurol Sci 2002;199:31-37.
19. Breton R, Mathieu J. Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy. Can J Cardiol 2009;25:e23-e27.
20. Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 2008;358:2688-2697.
21. Magrì D, Piccirillo G, Bucci E, Pignatelli G, Cauti FM, Morino S, et al. Increased temporal dispersion of myocardial repolarization in myo-tonic dystrophy type 1: beyond the cardiac conduction system. Int J Cardiol 2012;156:259-264.
22. Mathieu J, De Braekeleer M, Prévost C, Boily C. Myotonic dystrophy: clinical assessment of muscular disability in an isolated population with presumed homogeneous mutation. Neurology 1992;42:203-208.
23. Hannan PJ, Crow RS. Concerning the units for the QT interval corrected by Bazett's formula. Circulation 1997;96:3799.
24. Melacini P, Buja G, Fasoli G, Angelini C, Armani M, Scognamiglio R, et al. The natural history of cardiac involvement in myotonic dystrophy: an eight-year follow-up in 17 patients. Clin Cardiol 1988;11: 231-238.
25. Hayashi Y, Ikeda U, Kojo T, Nishinaga M, Miyashita H, Kuroda T, et al. Cardiac abnormalities and cytosine-thymine-guanine trinucleotide repeats in myotonic dystrophy. Am Heart J 1997;134(2 Pt 1):292-297.
26. Diedrich A, Jordan J, Shannon JR, Robertson D, Biaggioni I. Modulation of QT interval during autonomic nervous system blockade in humans. Circulation 2002;106:2238-2243.
27. Di Leo R, Rodolico C, De Gregorio C, Recupero A, Coglitore S, An-nesi G, et al. Cardiovascular autonomic control in myotonic dystrophy type 1: a correlative study with clinical and genetic data. Neuromuscul Disord 2004;14:136-141.
28. Olofsson BO, Niklasson U, Forsberg H, Bjerle P, Andersson S, Hen-riksson A. Assessment of autonomic nerve function in myotonic dystrophy. J Auton Nerv Syst 1990;29:187-192.
29. Pierangeli G, Lugaresi A, Contin M, Martinelli P, Montagna P, Parchi P, et al. Autonomic nervous system function in myotonic dystrophy. Ital J Neurol Sci 1992;13:589-592.
30. Inoue K, Ogata H, Matsui M, Hayano J, Miyake S, Kumashiro M, et al. Assessment of autonomic function in myotonic dystrophy by spectral analysis of heart-rate variability. J Auton Nerv Syst 1995;55:131-134.
31. Rana BS, Band MM, Ogston S, Morris AD, Pringle SD, Struthers AD. Relation of QT interval dispersion to the number of different cardiac abnormalities in diabetes mellitus. Am J Cardiol 2002;90:483-487.
32. Behr E, Wood DA, Wright M, Syrris P, Sheppard MN, Casey A, et al. Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet 2003;362:1457-1459.
33. Rautaharju PM, Nelson JC, Kronmal RA, Zhang ZM, Robbins J, Gottdiener JS, et al. Usefulness of T-axis deviation as an independent risk indicator for incident cardiac events in older men and women free from coronary heart disease (the Cardiovascular Health Study). Am J Cardiol 2001;88:118-123.
34. Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Car-diovasc Res 1997;33:13-22.
35. Bhakta D, Lowe MR, Groh WJ. Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I. Am Heart J 2004;147:224-227.